EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Changes in bone mineral density in patients with Pagets disease treated with alendronate



Changes in bone mineral density in patients with Pagets disease treated with alendronate



Journal of Bone & Mineral Research 14(SUPPL 1): S541, Sept




(PDF emailed within 1 workday: $29.90)

Accession: 034550361

Download citation: RISBibTeXText



Related references

Effects of alendronate or alfacalcidol on bone metabolic indices and bone mineral density in patients with ophthalmologic disease treated with glucocorticoid. Modern Rheumatology 24(4): 671-676, 2015

Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: a prospective study. Osteoporosis International 21(9): 1565-1571, 2011

Changes in bone mineral density following discontinuation or continuation of alendronate therapy in glucocorticoid-treated patients: a retrospective, observational study. Arthritis and Rheumatism 48(4): 1102-1108, 2003

Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease. Gastroenterology 119(3): 639-646, September, 2000

Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass. Journal of Musculoskeletal & Neuronal Interactions 11(1): 34-45, 2012

Bone mineral density and bone turnover in osteoporotic women treated by pamidronate and shifting to alendronate or not. Clinical Rheumatology 20(5): 431, 2001

Urine Calcium and Bone Mineral Density in Calcium Stone-Forming Patients Treated with Alendronate and Hydrochlorothiazide. Urologia Internationalis 97(3): 292-298, 2016

A randomized, double-blind, placebo-controlled study to evaluate the effects of alendronate on bone mineral density and bone remodelling in perimenopausal women with low bone mineral density. Journal of Obstetrics and Gynaecology Canada 36(11): 976-982, 2015

Comparison of bone and total alkaline phosphatase and bone mineral density in postmenopausal osteoporotic women treated with alendronate. Osteoporosis International 12(4): 279-288, 2001

Effects of alendronate on bone mineral density and bone metabolic markers in postmenopausal asthmatic women treated with inhaled corticosteroids. Metabolism Clinical and Experimental 54(1): 85-90, 2005

Effects of alendronate on bone mineral density and bone metabolic markers in postmenopausal asthmatic women treated with inhaled corticosteroids. Metabolism: Clinical and Experimental 54(1): 85-90, 2004

Alendronate increases lumbar spine bone mineral density in patients with Crohns disease A double blind controlled study. Clinical Nutrition (Edinburgh) 19(Supplement 1): 20, August, 2000

Effects of menatetrenone and/or alendronate on bone mineral density of tibiae in phenytoin treated rats. Calcified Tissue International 72(4): 393, April, 2003